Offer - Urjas Oil for just ₹ 1
Palicalm ER 3 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Schizophrenia. Secondary and off-label uses of Palicalm ER 3 Tablet have also been mentioned below.
The correct dosage of Palicalm ER 3 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Palicalm ER 3 Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Palicalm ER 3 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Palicalm ER 3 Tablet's effect during pregnancy is Unknown and Unknown while nursing. In addition, Palicalm ER 3 Tablet's effects on the liver, heart and kidney are discussed below in the Palicalm ER 3 Tablet related warnings section.
Palicalm ER 3 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dementia, Tardive Dyskinesia, Heart Disease are examples of such conditions. The section on Palicalm ER 3 Tablet contraindications lists all such conditions.
Additionally, Palicalm ER 3 Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Palicalm ER 3 Tablet is not safe while driving, and is not addiction.
Palicalm ER 3 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Palicalm ER 3 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Palicalm in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Palicalm ER 3 Tablet safe during breastfeeding?
Information about safety of Palicalm for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Palicalm ER 3 Tablet on the Kidneys?
Kidney can be affected by Palicalm. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Palicalm ER 3 Tablet on the Liver?
Palicalm can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Palicalm ER 3 Tablet on the Heart?
There may be an adverse effect on the heart after taking Palicalm. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Palicalm ER 3 Tablet unless your doctor advises you to do so -
Is this Palicalm ER 3 Tablet habit forming or addictive?
No, you will not get addicted to Palicalm ER 3 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Palicalm ER 3 Tablet can make you feel drowsy.
Is it safe?
Palicalm ER 3 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Palicalm ER 3 Tablet can help with mental disorders.
Interaction between Food and Palicalm ER 3 Tablet
There isn't any research available on the side effects of taking Palicalm ER 3 Tablet with food.
Interaction between Alcohol and Palicalm ER 3 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Palicalm ER 3 Tablet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 973-975
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Invega® (paliperidone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Invega Sustenna® (paliperidone palmitate)
